Search research articles
Contact Us
Filters
Showing results (221-230 of 333) with videos related to
Page
of 34
Sort By:
Canadian Liver Journal
|
August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study
Brian Conway, Julie Bruneau, Curtis Cooper, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 6, 2023
Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings
William W L Wong, Josephine Wong, Karen E Bremner, et al.
Science Advances
|
May 29, 2026
Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse models
Seung Bum Park, Jaime Sánchez-Meza, Regina Umarova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 24, 2018
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh, William W L Wong, Beate Sander, et al.
Journal of Gastroenterology and Hepatology
|
February 17, 2015
Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis
Raoel Maan, Adriaan J van der Meer, Bettina E Hansen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
Mayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.
Journal of Viral Hepatitis
|
August 6, 2021
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study
William M Lee, Wendy C King, Harry L A Janssen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2016
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason Grebely, Gregory J Dore, Stefan Zeuzem, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
March 7, 2024
Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario
Mia J Biondi, Kate Lynch, Natalie Floriancic, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 333) with videos related to
Sort By:
Page
of 34
Canadian Liver Journal
|
August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study
Brian Conway, Julie Bruneau, Curtis Cooper, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 6, 2023
Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings
William W L Wong, Josephine Wong, Karen E Bremner, et al.
Science Advances
|
May 29, 2026
Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse models
Seung Bum Park, Jaime Sánchez-Meza, Regina Umarova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 24, 2018
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh, William W L Wong, Beate Sander, et al.
Journal of Gastroenterology and Hepatology
|
February 17, 2015
Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis
Raoel Maan, Adriaan J van der Meer, Bettina E Hansen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 12, 2019
Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
Mayur Brahmania, Manuel Lombardero, Bettina E Hansen, et al.
Journal of Viral Hepatitis
|
August 6, 2021
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study
William M Lee, Wendy C King, Harry L A Janssen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 25, 2016
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason Grebely, Gregory J Dore, Stefan Zeuzem, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
March 7, 2024
Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario
Mia J Biondi, Kate Lynch, Natalie Floriancic, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Page
of 34